Search
Now showing items 1-5 of 5
Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission
(Elsevier, 2021-03)
Abstract
Introduction & objectives: The independent effect of liver biochemistries as a prognostic factor in patients with COVID-19 has not been completely addressed. We aimed to evaluate the prognostic value of abnormal ...
Simplified treatment of hepatitis C: another strategy to overcome the barriers to its elimination
(Medicina Buenos Aires, 2021-01)
Abstract in English, Spanish
The clinical management of hepatitis C virus (HCV) infection presents several challenges today. WHO's goal is to eliminate it by 2030. It is an ambitious goal and difficult to meet given the ...
Editorial: biomarkers in HBV and prediction of treatment response
(Wiley, 2021-01)
Hepatitis B cure is clinically defined as persistently undetectable HBsAg and hepatitis B virus (HBV) DNA in serum, with or without seroconversion to hepatitis B surface antibody (anti-HBs). ...
Hepatitis B virus vaccine and chronic kidney disease. The advances
(Sociedad española de nefrología, 2021-03)
Abstract
Background: Hepatitis B is an important agent of liver disease in patients with chronic kidney disease and chronic HBV infection promotes the development of CKD in the adult general population. Patients with CKD ...
Reply
(Elsevier, 2021-03)